Eur J Obstet Gynecol Reprod Biol X

[Kayla Munl]

Wehave remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse communities we serve.

Pregnancy and childbirth can be beautiful and fulfilling, but the experience can also be confusing and stressful. Birth doulas offer emotional, physical and informational support to expectant parents along the journey. Learn more about the role of a birth doula and what it's like to work with one.

Marcus Ortega, MD, and Youngwu Kim, MD, urogynecologists at Mass General, are pleased to offer full-spectrum of care for a wide variety of pelvic floor disorders at the convenient Danvers location including consultations, office visits, nonsurgical procedures, and outpatient surgery.

What can someone do before becoming pregnant to have a healthy pregnancy? Jeffrey Ecker, MD, chief of OBGYN at Mass General, discusses what people should think about before they get pregnant to have the best possible outcomes.

Who is at risk of developing cervical cancer? Is there a cure for cervical cancer? Rachel Clark Sisodia, MD, Gynecologic Oncologist, and Gynecologic Surgeon at Massachusetts General Hospital, discusses cervical cancer and why it is important to get regular check-ups.

The Department of Obstetrics & Gynecology at Mass General consistently ranks among the best women's health care providers in the country, offering innovative treatments from leading experts in obstetrics, gynecology, infertility, cancer, and urogynecology. Learn more about our department.

We use cookies and other tools to enhance your experience on our website and to analyze our web traffic. For more information about these cookies and the data collected, please refer to our Privacy Policy.

An Official journal of the European Urogynaecological Association (EUGA), le College National des Gynecologues et Obstetriciens Francais (CNGOF), the European Board and College of Obstetrics and Gynaecology (EBCOG) and the European Association of Perinatal Medicine (EAPM).

The European Journal of Obstetrics & Gynecology and Reproductive Biology has an open access companion journal European Journal of Obstetrics & Gynecology and Reproductive Biology: X which has the same aims and scope, editorial board and peer-review process. To submit to European Journal of Obstetrics & Gynecology and Reproductive Biology: X visit

The European Journal of Obstetrics & Gynecology and Reproductive Biology provides a forum for scientific and clinical professional communication in obstetrics and gynecology throughout Europe and the world.

Fields covered include obstetrics, prenatal diagnosis, maternal-fetal medicine, perinatology, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine, infertility, reproductive endocrinology, sexual medicine and reproductive ethics. The European Journal of Obstetrics & Gynecology and Reproductive Biology provides a forum for scientific and clinical professional communication in obstetrics and gynecology throughout Europe and the world.

Research is an integral component of obstetrics and gynecology to continue to improve women's health. The Obstetrics, Gynecology and Reproductive Biology Medical Education Research Division is dedicated to improving the health of women across a range of obstetric and gynecological areas, including:

The department's laboratory facilities for research and training include large core laboratory facilities on the eighth floor of University Hospitals MacDonald Women's Hospital. The laboratories are fully equipped for up-to-date research in molecular and cellular biology.

As members of the faculty of Case Western Reserve University/University Hospitals Cleveland Medical Center, researchers in the department have access to more than 40 core facilities. These include core laboratories services for:

Dr. Virginia D. Winn joined the faculty in the summer of 2014 coming from University of Colorado School of Medicine. Her research program focuses on improving the health of mothers and their offspring. Central to this goal are her investigations of human placental development and the obstetrical complications associated with placental dysfunction. Current studies focus predominately on the pregnancy-specific condition known as preeclampsia, characterized by new onset hypertension and proteinuria in the second half of pregnancy. The placenta is the inciting organ for this condition as once the placenta delivers the disease resolves. Investigations include determining the role of a number of placental expressed preeclampsia-associated genes (Siglec-6, leptin and PAPP-A2) on trophoblast differentiation and invasion, which is often impaired in placentas of pregnancies complicated by preeclampsia. The laboratory also carries out studies to determine the role of endothelial progenitor cells in preeclampsia pathogenesis as well as determine biomarkers of disease. A second line of investigation focuses on determining the impact of pregnancy on the maternal immune system and dissecting the mechanism by which pregnancy ameliorates rheumatoid arthritis. These studies also address the mechanisms that allow for maternal-fetal tolerance. A recent line of investigation for Dr. Winn is developing methods to assess human placental function during an ongoing pregnancy through assessment of placental exosomes in the maternal blood. Learn more about Winn Lab here.

Dr. Matteo A. Mol, PhD, is an Assistant Professor in the Department of Obstetrics and Gynecology at Stanford University. He is a member of the Division of Reproductive, Stem Cell and Perinatal Biology, as well as the Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact.

In the summer of 2023, Dr. Mol joined Stanford University as an Assistant Professor. His work focuses on investigating the mechanisms of human embryo implantation. The successful implantation of an embryo is crucial for the establishment of a healthy pregnancy. During the transition between the first and second week of gestation, the human embryo must securely implant into the maternal uterus, initiating development of the placenta to receive necessary nutrients and oxygen for its growth until birth.

Dr. Roger Pedersen received degrees in biology from Stanford University (A.B, 1965) and Yale University (Ph.D., 1970) and did postdoctoral work at Johns Hopkins University. In 1971, he joined the University of California, San Francisco, where he studied developmental potency and cell fate in mammalian embryos. He served for 9 years as Director of the UCSF In Vitro Fertilization Laboratory (1992-2001). In 2001 Dr. Pedersen moved to the University of Cambridge, where he continued his research on human embryonic stem cells as Professor of Regenerative Medicine. The Cambridge Stem Cell Institute, which he co-founded, became the leading stem cell research center in the UK and Europe.

Dr. Vittorio Sebastiano joined the faculty in the fall of 2014. The thread of Ariadne that connects germ cells, preimplantation development and pluripotent stem cells is the focus of research in the Sebastiano Lab. The zygote originates from the fusion of two highly specialized germ cells (the sperm and the oocyte) and in a few days develops into a blastocyst with a pluripotent cell population (the inner cell mass). These cells diverge from the extraembryonic cells of the trophoectoderm (will form the placenta) and can give rise to embryonic stem cells, in which a perpetual pluripotent and undifferentiated state is maintained. The long-term goals of the Sebastiano Lab include: 1) Understanding the biology of germ cells and a their ability to sustain early phases of preimplantation development; 2) Understanding the mechanisms that regulate very early cell fate decisions in human embryos and 3) Understanding the biology of Pluripotent Stem Cells and the mechanisms that lead to their formation also in the context of iPSCs derivation. Learn more about Sebastiano Lab here.

The European Journal of Obstetrics & Gynecology and Reproductive Biology is a monthly peer-reviewed medical journal covering obstetrics and gynecology and reproductive biology. It was originally established as Nederlandsch Tijdschrift voor Verloskunde en Gynaecologie in 1889, briefly renaming itself European Journal of Obstetrics and Gynecology in 1971, and acquiring its current name in 1972.[1] and is published by Elsevier. The editor-in-chief is Janesh K. Gupta (University of Birmingham). According to the Journal Citation Reports, the journal has a 2017 impact factor of 1.809.[2]

As faculty members of the MU School of Medicine, we are committed to training our medical students and resident physicians to become excellent obstetrician-gynecologists. Furthermore, our scientists are actively engaged in innovative research that uses basic, clinical and translational approaches to improve the health of women and children.

The Department values diversity and inclusion within our community. We are committed to an environment that supports faculty, staff, learners, and patients from all walks of life. For more information, please see the School of Medicine Office of Diversity and Inclusion.

Our residency program is fully accredited by the Accreditation Council for Graduate Medical Education. Our most recent re-accreditation was March 2012 and our next accreditation site visit is anticipated in 2022.

3a8082e126